Dhaka Medical College Shares Results of Randomized Controlled Trial: Ivermectin & Doxycycline Benefits Patients with Mild to Moderate COVID-19

Dhaka Medical College Shares Results of Randomized Controlled Trial Ivermectin & Doxycycline Benefits Patients with Mild to Moderate COVID-19

Dhaka Medical College and Hospital, a public medical college and hospital based in Dhaka, the capital of Bangladesh, houses one of the most prestigious medical schools and the country’s largest tertiary care hospital. Known as the most advanced of health institutions in this country with a population of 161.5 million—Bangladesh, the 8th most populous nation in world with an entrepreneurial spirit and nascent economy—the nation emerges as a research center targeting pragmatic and economical approaches to treating COVID-19. The combination of Ivermectin and doxycycline has become front and center in that strategy, with the goal of ensuring a pragmatic, safe and effective treatment for COVID-19.  Recently, Dhaka Medical College produced the results of a randomized controlled study demonstrating the efficacy of ivermectin as a treatment for COVID-19. Although not as yet peer reviewed or even documented for preprint server, TrialSite shares with the TrialSite Network worldwide a description of the study results as well as the study protocol. The findings appear to indicate the potential benefit of ivermectin and doxycycline for patients with mild to moderate SARS-CoV-2 infection. Howev...

Note:  If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).

Personal
$5 / Month
Individuals at home that are reading our content for personal health care or other non-professional reasons.
Like a Starbucks a month
Personal - Single Payment
$50 for 1 Year
Individuals - reading for personal reasons who prefer to pay for one year in advance with no recurring billing.
18% discount to monthly
Professional
$12 / Month
Professionals from the healthcare industry who are subscribing on behalf of their company for work reasons.
Way better than coffee